DIALYSIS · CCN 212613

DaVita Pasadena Dialysis

PASADENA, MD 21122

DialysisProfitDaVita
$6.8M
TOTAL REVENUE
33.2%
OPERATING MARGIN
3 / 5
STAR RATING
13
QUALITY MEASURES
DaVita
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$6.8M
Total costs
$4.6M
Operating income (rev − costs)
$2.3M
Operating margin
33.2%
Total charges
$6.9M
Total treatments
16,585
Dialysis stations
30

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

13 quality measures

MeasureScoreDenominatorPeriod
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
0.84112—
Fistula Rate
DFC_FISTULA_RATE
61.9146—
Five Star Rating
DFC_FIVE_STAR
3——
First Year Standardized Kidney Transplant Waitlist Ratio
DFC_FYSWR
0.4849—
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
3——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
102.3121—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0.52——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
15146—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
20.8443—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
15.4112—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
21.969—
Standardized ED Visits Ratio
DFC_SEDR
0.7282—
Patient Transfusion Rate
DFC_TRANSFUSION_RATE
33.968—